Synthesis of 2-[5,6-diphenyl-3(2H)-pyridazinone-2-yl]acetamide and 3-[5,6-diphenyl-3(2H)-pyridazinone-2-yl]propanamide derivatives as analgesic and anti-inflammatory agents

Turkish Journal of Pharmaceutical Sciences

Volumn 4, Issue 2, 2007, Pages 57-70

  Doǧruer, Deniz S ^a   Ünlü, Serdar ^a   Küpeli, Esra ^a   Banogǧlu, Erden ^a   Şahin, M Fethi ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

5,6 Diphenyl 3(2H) pyridazinone; Analgesic and anti inflammatory activity; Cyclooxygenase inhibition

Indexed keywords

1,4 BENZOQUINONE; 2 [5,6 DIPHENYL 3(2H) PYRIDAZINON 2 YL]ACETAMIDE DERIVATIVE; 3 [5,6 DIPHENYL 3(2H) PYRIDAZINON 2 YL]PROPANAMIDE DERIVATIVE; ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; EMORFAZONE; INDOMETACIN; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PAW EDEMA; STOMACH HEMORRHAGE; STOMACH LESION; WRITHING TEST;

EID: 34547522724     PISSN: 1304530X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Brooks, P., Emery, P., Evans, J. F., Fenner, H., Hawkey, C. J., Patrono, C., Smolen, J., Breedveld, F., Day, R., Dougados, M., Ehrich, E. W., Gijon-Banos, J., Kvien, T. K., Van Rijswijk, M. H., Warner, T., Zeidler, H., "Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2" Rheumatology, 38, 779-788, 1999.
2. Hawkey, C. J., "COX-2 inhibitors" The Lancet, 353, 307-314, 1999.
3. Ryn, J. V., Trummlitz, G., Pairet, M., "COX-2 Selectivity and inflammatory processes" Curr. Med. Chem., 7, 1145-1161, 2000.
4. Dannhardt, G., Laufer, S., "Structural approaches to explain the selectivity of COX-2 inhibitors: Is there a common pharmacophore" Curr. Med. Chem., 7, 1101-1112, 2000.
5. Hoffmann, C., "COX-2 in brain and spinal cord - implications for therapeutic use" Curr.Med.Chem., 7, 1113-1120, 2000.
6. Navidpour, L., Shafaroodi, H., Abdi, K., Amini, M., Ghahremani, M. H., Dehpour, A. R., Shafiee, A., "Design, synthesis, and biological evaluation of substituted 3-alkylthio-4,5-diaryl-4H-1,2,4-triazoles as selective COX-2 inhibitors" Bioorg. Med. Chem., 14, 2507-2517, 2006.
7. Shin, S. S., Noh, M. S., Byun, Y. J., Choi, J. K., Kim, J. Y., Lim, K. M., Ha, J. Y., Kim, J. K., Lee, C. H., Chung, S., "2,2-Dimethyl-4,5- diaryl-3(2H)furanone derivatives as selective cyclooxygenase-2 inhibitors" Bioorg. Med. Chem., 11, 165-168, 2001.
8. Menozzi, G. Merello, L., Fossa, P., Mosti, L., Piana, A., Mattioli, F., "4-Substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties" IL Farmaco, 58, 795-808, 2003.
9. Shin, S. S., Byun, Y., Lim, K. M., Choi, J. K., Lee, K. W., Moh, J. H., Kim, J. K., Yeon, Y. S., Kim, J. Y., Choi, Y. H., Koh, H. J., Park, Y. H., Oh, Y. I., Noh, M. S., Chung, S. "In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxynenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives" J. Med. Chem., 47, 792-804, 2004.
10. Sakya, S. M., DeMello, K M. L., Minich, M. L., Rast, B., Shavnya, A., Rafka, R. J., Koss, D. A., Cheng, H., Li, J., Jaynes, B. H., Ziegler, C. B., Mann, D. W., Petras, C. F., Siebel, S. B., Silvia A. M., George, D. M., Lund, L. A., Denis, S. S., Hickman, A., Haven, M. L., Lynch, M. P., "5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog" Bioorg. Med. Chem. Lett., 16, 288-292, 2006.
11. Kalgutkar, A. S., Marnett, A. B., Crews, B. C., Remmel, R. P., Marnett, L. J., "Ester and amide derivatives of the nonsteroidal anti-inflammatory drug, indometacin, as selective cyclooxygenase-2 inhibitors" J. Med. Chem., 43, 2860-2870, 2000.
12. Kalgutkar, A. S., Rowlinson, S. W., Crews, B. C., Marnett, L. J., "Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors" Bioorg. Med. Chem. Lett., 12, 521-524, 2002.
13. Takaya, M., Sato, M., Terashima K., Tanizawa, H "A new nonsteroidal analgesic-antiinflammatory agent. Synthesis and activity of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone and related compounds" J. Med. Chem., 22(1), 53-58, 1979.
14. Heinisch G., and Frank, H., "Pharmacologically active pyridazine derivatives" Prog. Med. Chem. 27, 1-35, 1990.
15. Chintakunta, V. K., Akella, V., Vedula, M. S., Mamnoor, P. K., Mishra, P., Casturi, S. R., Vangoori, A., Rajagopalan, R., "3-O-substituted benzyl pyridazinone derivatives as COX inhibitors" Eur. J. Med. Chem. 37, 339-347, 2002.
16. Doǧruer, D. S., Şahin, M.F., Ünlü, S., Ito, S., "Studies on some 3(2H)-pyridazinone derivatives with antinociceptive activity"Arch. Pharm. Pharm. Med. Chem., 333, 79-86, 2000.
17. Doǧruer, D. S., Şahin, M.F., Küpeli, E., Yeşilada, E., "Synthesis and analgesic and anti-inflammatory activity of new pyridazinones" Turk J. Chem. 27, 727-738, 2003.
18. Şüküroǧlu, M., Küpeli, E., Banoǧlu, E., Ünlü, S., Yeşilada, E., Şahin, M.F., "Synthesis and analgesic activity of some 4,6-disubstituted-3(2H) -pyridazinone derivatives" Arzneim. -Forsch./Drug Res. 56(5), 337-345, 2006.
19. Ranade, A.C., Mali, R.S., Kurnawal, V. M., "An unusual reaction of a phosphorane with benzoins: formation of 1,2-dicarbonyl & 1,4-dicarbonyl compounds" Indian Journal of Chemistry, 23B, 514-517, 1984.
20. Taylor, H. M., Hauser, C. R., "Conjugate addition of α - dimethylaminophenylacetonitrile with benzalacetophenone and ethyl cinnamate by means of potassium amide" J. Am. Chem. Soc. 82, 1790-1792, 1960.
21. Baddar, F.G., El-Habashi, A., Fateen, A.K., "Pyridazines. II. The action of Grignard reagents on 6-aryl-2,3,4,5-tetrahydro- and -2,3-dihydropyridazin-3-ones" J. Chem. Soc. 3342-3348, 1965.
22. Okun, R., Liddon, S. C., Lasagnal, L., "The effects of aggregation, electric shock, and adrenergic blocking drugs on inhibition of the "writhing syndrome" J. Pharmacol. Exp. Ther., 139, 107-114,1963.
23. Kasahara, Y., Hikino, H., Tsurufuji, S., Watanabe, M., Ohuchi, K., "Antiinflammatory actions of ephedrines in acute inflammations" Planta Med. 51, 325-331, 1985.
24. Brideau, C., Kargman, S., Liu, S., Dallob, A. L., Ehrich, E. W., Rodger, I. W., Chan, C. C., "A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors" Inflamm. Res. 45, 68-74, 1996.
25. Patrignani, P., Panara, M. R., Greco, A., Fusco, O., Natoli, C., Iacobelli, S., Cipollone, F., Ganci, A., Creminon, C., Maclouf, J., Patrono, C., "Biochemical and Pharmacological Characterization of the Cyclooxygenase Activity of Human Blood Prostaglandin Endoperoxide Synthases" J. Pharmacol. Exp. Ther. 271(3), 1705-1712, 1994.
26. Vinegar, R., Schreiber, W., Hugo, R., "Biphasic development of carrageenin edema in rats" J. Pharmacol. Exp. Ther. 166, 96-103, 1969.
27. Vinegar, R., Truax, J. F., Selph, J. L., Johnston, P. R., Venable, A. L., McKenzie, K. K., "Pathway to carrageenan-induced inflammation in the hind limb of the rat" Fed. Proc. 46, 118-126, 1987.
28. Kargman, S., Wong, E., et al. "Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and 2 in intact cells" Biochem. Pharmacol. 52, 1113-1125, 1996.
29. Smith, C. J., Zhang, Y., Koboldt, C. M., et al. "Pharmacological analysis of cyclooxygenase-1 in inflammation" Proc. Natl. Acad. Sci. USA, 95, 13313-13318, 1998.
30. Sato, M., Ishizuka, Y., Yamaguchi, A., "Pharmacological investigation of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone" Arzneim.-Forsch./Drug Res. 31, 1738-1745, 1981.
31. Sato, M., Yamaguchi, A., "Studies on mechanism of action of Emorfazone" Arzneim.-Forsch./Drug Res. 32, 379-382, 1982.